166 related articles for article (PubMed ID: 18359203)
1. Efficacy of pregabalin in depressive symptoms associated with generalized anxiety disorder: a pooled analysis of 6 studies.
Stein DJ; Baldwin DS; Baldinetti F; Mandel F
Eur Neuropsychopharmacol; 2008 Jun; 18(6):422-30. PubMed ID: 18359203
[TBL] [Abstract][Full Text] [Related]
2. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
Arnold LM; Leon T; Whalen E; Barrett J
Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
[TBL] [Abstract][Full Text] [Related]
3. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
[TBL] [Abstract][Full Text] [Related]
4. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
Bandelow B; Wedekind D; Leon T
Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin: dose-response relationship in generalized anxiety disorder.
Boschen MJ
Pharmacopsychiatry; 2012 Mar; 45(2):51-6. PubMed ID: 22086745
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin for the treatment of generalized anxiety disorder.
Wensel TM; Powe KW; Cates ME
Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
Bech P
Pharmacopsychiatry; 2007 Jul; 40(4):163-8. PubMed ID: 17694480
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
11. Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
Baldwin DS; Schweizer E; Xu Y; Lyndon G
Eur Neuropsychopharmacol; 2012 Feb; 22(2):137-42. PubMed ID: 21839620
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy of pregabalin in generalized anxiety disorder.
Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
[TBL] [Abstract][Full Text] [Related]
13. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin: From molecule to medicine.
Kavoussi R
Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
[TBL] [Abstract][Full Text] [Related]
15. Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis.
Stein DJ; Bruce Lydiard R; Herman BK; Mandel FS
Int Clin Psychopharmacol; 2009 May; 24(3):126-32. PubMed ID: 19352198
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study.
Karaiskos D; Pappa D; Tzavellas E; Siarkos K; Katirtzoglou E; Papadimitriou GN; Politis A
Int J Geriatr Psychiatry; 2013 Jan; 28(1):100-5. PubMed ID: 22431439
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
[TBL] [Abstract][Full Text] [Related]
18. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder.
Boschen MJ
Can J Psychiatry; 2011 Sep; 56(9):558-66. PubMed ID: 21959031
[TBL] [Abstract][Full Text] [Related]
20. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
